Burk Holdings’s Impact BioMedical IBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11 Hold
2
– – ﹤0.01% 957
2026
Q2
$12 Hold
2
– – ﹤0.01% 643
2026
Q1
$16 Buy
+2
New +$13 ﹤0.01% 676

Other funds holding IBO

Burk Holdings's IBO Position: Q3 2026 in Review

Burk Holdings held its Impact BioMedical (IBO) position steady in Q3 2026 at 2 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Burk Holdings first reported a position in IBO in Q1 2026 and has held it in 3 quarters since. The position peaked at $16 in Q1 2026. 18 funds tracked by Wall St. Rank hold IBO as of Q3 2026.

  • Burk Holdings held 2 shares of Impact BioMedical worth $11 as of Q3 2026.
  • Burk Holdings left its Impact BioMedical share count unchanged in Q3 2026.
  • Impact BioMedical made up ﹤0.01% of Burk Holdings's portfolio in Q3 2026, its #957 holding.
  • Burk Holdings first reported a position in Impact BioMedical in Q1 2026 and has held it in 3 quarters since.
  • Burk Holdings's Impact BioMedical position peaked at $16 in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Impact BioMedical as of Q3 2026.

Based on Burk Holdings's 13F filing for Q3 2026, filed 5 Nov 2026.